The Internet provides an ever-growing source of information, both for healthcare professionals and consumers, concerning medicinal products. Although many countries around the world have developed regulations intended to govern the promotion of medicinal products, the very nature of the Internet makes it difficult to police. There are both opportunities and risks for the pharma company engaging in promotion using social media. This audio conference presentation examines the laws currently in place in the European Union governing promotion of medicinal products, and how these apply to promotion on the Internet and, in particular, via social media. Our speaker also examines the risks pharmaceutical companies face when establishing corporate websites and social media accounts.

This audio conference covers:

• EU laws governing promotion of medicinal products
• How these laws apply to social media and promotion on the Internet
• The potential of social media as a pharma marketing vehicle
• The risks associated with a social media presence for pharmaceutical companies

About the speaker:

Elisabethann Wright has advised on EU law while in private practice and when working with international institutions. She focuses on European Union (EU) law relating to life sciences, with particular emphasis on pharmaceutical law, medical devices, food law, and the environment. This includes classification of products, establishment of regulatory pathways, including related regulatory obligations, pharmacovigilance obligations, promotion and marketing of products, sales agreements, clinical trial agreements, adverse event reporting, product withdrawals and challenges to related national authority and EU Institution decisions.

Elisabethann has extensive experience in litigation before the European Court of Justice, the European Court of First Instance, and the European Free Trade Agreement (EFTA) Court. She was also a Référendaire at the Court of Justice of the European Union for many years. Her experience includes successful challenges, on behalf of industry clients, to decisions of EU institutions, and advising governments and public bodies on their national and international obligations arising from the EC Treaty and the European Economic Area (EEA) Agreement. Her practice includes advising on the challenge ability of decisions of EU Institutions and the validity of EU legislation.

Who should attend?

• Legal Counsel
• Marketing
• Public Relations
• Sales/Business Development
• IS/IT